Optimizing the Use of Entonox® During Screening Colonoscopy

Last updated: September 19, 2019
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Overall Status: Completed

Phase

4

Condition

Pain

Colon Cancer Screening

Treatment

N/A

Clinical Study ID

NCT01865721
STH16359
2012-003342-33
  • Ages 60-75
  • All Genders

Study Summary

This study will randomise patients undergoing screening colonoscopy to receive Entonox either continuously or as required.

Both these methods are used in the published studies of Entonox and in clinical practice.

Null hypothesis There will be no difference in pain levels between these two methods of Entonox administration

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Having a bowel cancer screening programme colonoscopy

Exclusion

Exclusion Criteria:

  • Contraindications to Entonox

  • Previous bowel resections

Study Design

Total Participants: 100
Study Start date:
January 01, 2013
Estimated Completion Date:
April 30, 2014

Connect with a study center

  • Sheffield Teaching Hospitals NHS Foundation Trust

    Sheffield, South Yorkshire S5 7AU
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.